Zynex Announces a Second Utility Patent for Its Blood Volume Monitor
Retrieved on:
Wednesday, January 6, 2021
(NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported it has obtained a second U.S. Utility patent for its Blood Volume Monitor Device.
Key Points:
- (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported it has obtained a second U.S. Utility patent for its Blood Volume Monitor Device.
- Thomas Sandgaard, the inventor, has assigned the patent to Zynex's subsidiary, Zynex Monitoring Solutions.
- Thomas Sandgaard, CEO of Zynex said: "I am excited to receive additional patent protection for our non-invasive blood volume/blood loss technology.
- Zynex also has a blood volume monitor for use in hospitals and surgery centers.